Clinton Group’s Bristol-Myers Squibb BMY Stock Holding History

Clinton Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$903K	Sell	14,547 -40,403	-74%	-$2.4M	0.32%	89
2018 Q2	$3.04M	Sell	54,950 -35,045	-39%	-$1.89M	0.48%	72
2018 Q1	$5.69M	Buy	89,995 +4,837	+6%	+$311K	0.61%	42
2017 Q4	$5.22M	Buy	+85,158	New	+$5.33M	0.46%	67
2017 Q3	–	Sell	-77,616	Closed	-$4.33M	–	397
2017 Q2	$4.33M	Buy	+77,616	New	+$4.22M	0.44%	64
2017 Q1	–	Sell	-154,719	Closed	-$9.04M	–	922
2016 Q4	$9.04M	Buy	154,719 +115,755	+297%	+$6.33M	0.53%	35
2016 Q3	$2.1M	Buy	+38,964	New	+$2.5M	0.1%	280
2016 Q2	–	Sell	-8,306	Closed	-$531K	–	882
2016 Q1	$531K	Sell	8,306 -21,253	-72%	-$1.34M	0.03%	604
2015 Q4	$2.03M	Buy	29,559 +23,033	+353%	+$1.52M	0.16%	197
2015 Q3	$386K	Buy	+6,526	New	+$414K	0.04%	499
2015 Q2	–	Sell	-27,408	Closed	-$1.77M	–	586
2015 Q1	$1.77M	Buy	+27,408	New	+$1.72M	0.46%	45
2014 Q4	–	Sell	-5,690	Closed	-$291K	–	472
2014 Q3	$291K	Buy	+5,690	New	+$284K	0.12%	275

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Clinton Group's BMY Position: Q3 2018 in Review

Clinton Group reduced its Bristol-Myers Squibb (BMY) stake by 74% in Q3 2018, selling an estimated $2.4M and leaving 14,547 shares worth $903K. The position accounts for 0.32% of the portfolio, ranked #89.

Clinton Group first reported a position in BMY in Q3 2014 and has held it in 12 quarters since. The position peaked at $9.04M in Q4 2016. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

Clinton Group held 14,547 shares of Bristol-Myers Squibb worth $903K as of Q3 2018.
Clinton Group sold 40,403 Bristol-Myers Squibb shares in Q3 2018, an estimated $2.4M.
Bristol-Myers Squibb made up 0.32% of Clinton Group's portfolio in Q3 2018, its #89 holding.
Clinton Group first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 12 quarters since.
Clinton Group's Bristol-Myers Squibb position peaked at $9.04M in Q4 2016.
1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.